Should I talk about genetic testing before breast cancer surgery?

Genetic counseling for breast cancer usually means talking with a genetics professional about inherited (germline) risk — and whether testing such as BRCA1/BRCA2 (and related genes) is appropriate for you.

This is about inherited risk in you (and sometimes family). It is not the same as tumor subtype testing (ER/PR/HER2).

Results can change the operation itself — for example whether mastectomy, surgery on the other breast, or risk-reducing options enter the discussion.

If a result could change an irreversible surgery choice, ask whether counseling should happen before you lock a date.

Counseling is more often discussed when risk factors are present — but criteria evolve, and your team may still recommend it without a dramatic family history in breast cancer.

• Personal or family history that raises hereditary risk questions
• Younger age at diagnosis (criteria vary — ask for your situation)
• Triple-negative disease in some guidelines/contexts
• Known familial mutation, or a relative with BRCA-class results
• Considering surgery on the other breast for risk reduction

Ask: “Do I meet criteria for genetic counseling before surgery — and why or why not?”

Triple-negative breast cancer often raises genetic counseling — many teams discuss germline testing because hereditary findings can change surgery planning and family risk conversations. It is common to ask, not automatic that every TNBC person has a BRCA mutation.

Ask whether TNBC alone tips counseling for you — and what a result would change.

Tumor subtype describes breast cancer’s biology. Germline genetics describes inherited risk that can affect surgery and family implications.

You may need both conversations. Do not treat a pathology receptor result as a BRCA answer.

A pathogenic (disease-causing) result in a high-risk gene may change what surgery options are discussed — including mastectomy and whether the other breast is part of the plan.

• Local surgery recommendations may shift toward more extensive risk-reducing options for some people
• Reconstruction timing may be discussed alongside a larger operation
• Systemic therapy and screening plans for you (and relatives) may also change later

Ask what a positive result would change for your operation — in plain language — before assuming one path.

BRCA1 and BRCA2 are the genes people hear about most — but they are not the only ones that can matter in breast cancer. Many counseling conversations use a multi-gene panel that may include other high- or moderate-risk genes.

You do not need to memorize gene names. Ask which genes are on the panel and which results would change the surgery decision.

A BRCA test (often as part of a broader panel) looks for inherited gene changes that can raise lifetime cancer risk and, when positive, may change surgery and family counseling in breast cancer. It does not report tumor ER/PR/HER2 subtype.

Ask what the test can and cannot answer before treating it like a tumor-biology report.

A negative result does not mean “zero risk,” and a VUS (variant of uncertain significance) is not the same as a positive result in breast cancer.

Do not redesign surgery around a VUS unless your genetics and surgical teams agree it should change the plan.

Waiting for genetics can be appropriate when results would change the operation. Waiting is not automatic for everyone — urgency depends on your breast cancer situation.

Ask for a clear timeline: what waits, what can start, and what would make waiting unsafe.

Surgery on the other breast (contralateral risk-reducing mastectomy) is a separate decision. Genetics may raise it — it is not automatic for every positive result, and it is not required for every person with breast cancer.

Ask whether the other breast is recommended, optional, or something that can wait.

Yes. Most people diagnosed with breast cancer do not have a known BRCA1 or BRCA2 mutation. Breast cancer can occur without those genes — and a negative BRCA result does not mean cancer was “impossible” or that family history never matters.

BRCA is important when positive — it is not the only explanation for breast cancer.

A parent (or other close relative) with breast cancer can raise questions about inherited risk — but it does not by itself mean you will get the same cancer, or that you must have a BRCA mutation.

Ask for a counseling referral when history is concerning — do not self-calculate lifetime risk from one relative’s story.

Counseling and testing can take days to weeks depending on access, prior records, and lab turnaround in breast cancer.

A typical path: referral → counseling discussion → decide whether to test → sample → results visit → update the surgical plan if needed in breast cancer.

• Bring family-history details you know (even if incomplete)
• Bring pathology and imaging summaries
• Ask who will explain results to your surgical team

Counseling is a conversation first — testing is not automatic at every visit.

For breast cancer, before locking surgery, confirm whether genetics is still open:

• Whether counseling is recommended for you
• Whether a result would change the operation
• Whether waiting is safe in your cancer timeline
• What happens if results arrive after a provisional surgery plan

Clear answers here prevent locking a date that genetics would reverse.

For breast cancer, if genetics may affect surgery, focus on:

• Ask whether you should have genetic counseling before a final surgery choice
• Ask whether a positive result would change lumpectomy vs mastectomy (or the other breast)
• Get a referral timeline — and what can proceed in parallel

A short “wait / don’t wait” answer from your team beats researching gene lists alone.

For breast cancer, common genetics-before-surgery mistakes include:

• Treating tumor subtype as germline genetics

  ER/PR/HER2 answers are not BRCA answers — ask for both when relevant.

• Locking mastectomy (or bilateral surgery) before results that could change the plan

  If genetics would reshape the operation, clarify timing first.

• Assuming every positive result means the same surgery

  Gene, personal history, and preferences still shape the conversation.

• Treating a VUS like a pathogenic mutation

  Uncertain variants usually should not drive irreversible surgery alone.